China Drug Promotion Association blasts Hunan drug tender: price reduction only

At the end of last month, Hunan Province completed a new round of centralized drug procurement tenders, taking the lead in the domestic county-level use of drugs, basic drugs, direct-to-net drugs ,"three bids in one" new procurement model, the local media on the procurement tender evaluation as "sword refers to the inflated price of drugs" - compared with the 2010 winning bid price in Hunan Province and the original average bid price of the surrounding six provinces, a decrease of about 10%, the province's public medical institutions are expected to reduce the cost of drugs by more than 2 billion yuan in 2015 But the tender was hard to accept in the eyes of pharmaceutical companies In addition to participating in the bidding of a number of pharmaceutical companies to protest, recently, by more than 60 domestic biopharmaceutical backbone enterprises, the Chinese Pharmaceutical Innovation Promotion Association published a "severe response" on its website, publicly criticized the Hunan Province Drug Tender Office, and in the title of the use of the word "bombarding": "China Pharmaceutical Promotion Association bombarded Hunan drug tender work." Drug prices are related to the vital interests of ordinary people, by the "bombarded" Hunan Province drug centralized procurement tender, cut in the end is a false high drug prices, or the lifeblood of pharmaceutical companies? at the end of last month, the China Pharmaceutical Promotion Association published on the official website of a "opinion on the 2015 Hunan Province drug centralized bidding and procurement work", the Hunan Province drug tender put forward a number of questions, that the tender "only to reduce the price as the ultimate goal, subjective and arbitrary color is stronger." "
February 4, the China Pharmaceutical Promotion Association once again published an article entitled "The head of the Hunan Provincial Drug Tendering Office threatened to sue the China Pharmaceutical Innovation Promotion Association, China Pharmaceutical Innovation Promotion Association to give a stern response", said Hu Zhushan, deputy director of the Hunan Pharmaceutical Tender Office, told the association that the above-mentioned opinions open to the Internet practice is illegal, Hunan Province Drug Tender office to go through legal proceedings to prosecute, asked to remove the letter of opinion and public apology It is also considered "not professional" to suggest that the above-mentioned opinion sits Wang Min, head of the research room of the China Pharmaceutical Promotion Association, would not disclose more information, saying that the relevant views and progress of the incident have been published through the official website: Wang Min: No progress, you want to know the situation on the official website, we do not accept interviews now it is understood that participating in the centralized procurement bidding from more than 30,000 enterprises from the country's 35,411 products, there are experts to participate in the bargaining revealed that the bargaining principle is "experts to give the price must not be higher than the price guide price and the last round of the enterprise bid price." Mr Hu, head of a drug sales company in Hunan province, says the drop in agreed prices is hard for them to accept: Mr Hu: In the middle of this tender, some of the drug's prices have been lowered by bargaining experts, and some have given up Some varieties even get rid of half the price Some of the decline is not so large, about 10% of us can accept, more than 10%, even 30% that is not acceptable, (down) half certainly impossible to do, all abandoned, bargaining varieties more than ten thousand bar, the last left is more than 5,000, the last half have given up Hu Rushan, Deputy Director of Hunan Drug Tendering Office: Hu Rushan: Strictly in accordance with our implementation plan, including on-site evaluation, pricing basis are in the program, the basis of expert negotiations is also in the program, may be the enterprise's awareness of related things is not enough the price of drugs is expensive or cheap, in the end who should decide? in this tender, Hunan Provincial Health and Family Planning Commission led, the provincial drug centralized procurement joint meeting member unit discipline inspection personnel formed a supervision group, from the provincial drug centralized procurement evaluation expert pool, according to the classification of experts randomly selected 60 experts with more than deputy senior titles They formed a committee of experts on centralized drug procurement evaluation, responsible for the new round of centralized procurement of drugs in Hunan Province, the subjective evaluation and bargaining of tender drugs but in Mr Hu's view, the price of drugs by experts, and can not convince them: Mr Hu: this expert is some clinical, how does he understand the price? This price should be the price bureau or the NDRC to discuss, this we can all accept, they can understand the cost of drug prices But the doctor is a doctor, how does he understand the price of medicine? He doesn't know Hu Rushan said, Hu Rushan: We are in accordance with the drug centralized procurement expert management methods inside, to our pharmaceutical experts and clinical experts divided into professional extraction it is understood that many of the experts involved in the bargaining are provisionally notified, the bid evaluation site is also strictly closed management, to take high-standard confidentiality measures Hu Rushan said that the purpose is not to want to negotiate by outside interference: Hu Rushan: mainly do not want outside intervention, because we also know that since it is bargaining, if the enterprise subjectively interfered with the consideration of experts, put in a lot of subjective factors, the price can be negotiated? Not that we suddenly attacked, panicked to get this thing done, it was well-arranged, but on the organization we strictly control the information with the outside world Mainly in order to be more rigorous and objective, let the voice of experts come out, the power to the experts Is the price after bargaining reasonable, in the end cut is the "false high" part or reasonable profit? An expert in pharmacy from Yiyang, Hunan Province, participated in the bargain, he said, some clinical must, good efficacy of the drug "cut price" is not much, the bargaining range is a number of auxiliary drugs and change dosage forms, packaging so-called new drugs China Pharmaceutical Promotion Association believes that this Hunan tender as the beginning of the 2015 non-base drug tender, has a hot needle attitude: is to see such a harsh tentative inquiry of the pharmaceutical companies do not accept the offer, if there is no large-scale pharmaceutical companies to withdraw from the tender, this may give the government a "drug price or can be down" positive signal But Mr Hu said, from the point of view of pharmaceutical companies, they still want to get more understanding: Mr Hu: medicine is the cure to save people's things, but it is also a commodity ah, but also to maintain a normal reasonable profit, there is no this profit, now labor wages, raw materials costs so high, manufacturers how to do it? A cut in the price is actually forcing you to give up the market February 3, Hunan Province Drug Central Procurement Management Office in the official website announced the results of the proposed winning bid, a total of 11,296 product rules winning the bid Mr Hu said they would also respond publicly to questions in the near future.